Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

New England Journal of Medicine - United States
doi 10.1056/nejmoa1005109
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Massachusetts Medical Society

Related search

Metformin in Patients With Type 2 Diabetes and Kidney Disease

JAMA - Journal of the American Medical Association
Medicine
2014English

Dulaglutide Slows Kidney Disease in Type 2 Diabetes

The Lancet
Medicine
2020English

Association of Hypothyroidism in Type 2 Diabetes Mellitus and Diabetic Kidney Disease

2020English

Dulaglutide Slows Kidney Disease in Type 2 Diabetes − Author's Reply

The Lancet
Medicine
2020English

Management of Type 2 Diabetes Mellitus in Chronic Kidney Disease

Current Medical Research and Opinion
Medicine
2014English

Inсretin-Based Therapy in Patients With Type 2 Diabetes and Chronic Kidney Disease

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Economic Burden of Moderate Chronic Kidney Disease in Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Cystatin C Study in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Medical News of North Caucasus
Medicine
2016English

Microvascular Outcomes in Type 2 Diabetes

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy